¼ãÊÖ¤ê¸ú²Ì¤ò¤¦¤¿¤¦Ž¢NMN¡×¤È¤¤¤¦¥µ¥×¥ê¥á¥ó¥È¤¬ÏÃÂê¤À¡£Æâ²Ê°å¤Î̾¼è¹¨»á¤Ï¡Ö»ä¤¬Ä´¤Ù¤¿¸Â¤ê¡¢NMN¤Î¸ú²Ì¤ò¸¡¾Ú¤¹¤ëÎ×¾²»î¸³¤Ïȯɽ¤µ¤ì¤Æ¤¤¤Þ¤»¤ó¡£¸ú²Ì¤Ï¤¢¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¤¬¡¢¤É¤ó¤Ê¥ê¥¹¥¯¤¬¤¢¤ë¤«¤âÉÔÌÀ¤Ç¤¹¡£»ä¤ÏÀäÂФ˰û¤ß¤Þ¤»¤ó¤·¡¢²È²¤äͧ¿Í¤Ë¤â´«¤á¤Þ¤»¤ó¡×¤È¤¤¤¦¡½¡½¡£
¼Ì¿¿¡áiStock.com¡¿AntonioGuillem
¢¨¼Ì¿¿¤Ï¥¤¥á¡¼¥¸¤Ç¤¹ - ¼Ì¿¿¡áiStock.com¡¿AntonioGuillem

¢£¼ãÊÖ¤ê¸ú²Ì¤¬´üÂÔ¤µ¤ì¤Æ¤¤¤ëNMN¤À¤¬¡Ä

NMN¥µ¥×¥ê¥á¥ó¥È¤¬ÏÃÂê¤Ë¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£

¥¢¥ó¥Á¥¨¥¤¥¸¥ó¥°¡¢¼ãÊÖ¤ê¤ÎºîÍѤ¬¤¢¤ë¤Ê¤É¤È¤·¤Æ¡¢¥µ¥×¥ê¥á¥ó¥È¤ÎÀ½Â¤ÈÎÇä¶È¼Ô¤ä¥¤¥ó¥Õ¥ë¥¨¥ó¥µ¡¼¤¬¾¦ÉʤȤ·¤ÆÈÎÇ䤷¤Æ¤¤¤Þ¤¹¡£¤Þ¤¿¡¢¼ãÊÖ¤ê¤À¤±¤Ç¤Ê¤¯¡¢ÅüǢɤò¤Ï¤¸¤á¤È¤·¤Æ¤µ¤Þ¤¶¤Þ¤Ê¼À´µ¤Ë¸ú²Ì¤¬¤¢¤ë¤È¤â¼çÄ¥¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

¤â¤·ËÜÅö¤Ê¤é¾¯¡¹¤ª¹â¤¯¤Æ¤âÀݼ褷¤Æ¤ß¤¿¤¤¤È¤³¤í¤Ç¤¹¤¬¡¢¸½»þÅÀ¤ÇÆþ¼ê¤Ç¤­¤ë¾ðÊó¤ÇȽÃǤ¹¤ë¸Â¤ê¤Ç¤Ï¡¢»ä¤Ê¤éÀݼ褷¤Þ¤»¤ó¤·¡¢²È²¤Ë¤â´«¤á¤Þ¤»¤ó¡£ÌµÎÁ¤Ç¤â·ù¤Ç¤¹¡£

¤½¤â¤½¤âNMN¤È¤Ï²¿¤Ç¤·¤ç¤¦¤«¡£

ʪ¼Á̾¡Ö¥Ë¥³¥Á¥ó¥¢¥ß¥É¥â¥Î¥Ì¥¯¥ì¥ª¥Á¥É¡×¤ÇƬʸ»ú¤ò¤È¤Ã¤ÆNMN¤È¸Æ¤Ó¤Þ¤¹¡£Àݼ褵¤ì¤¿NMN¤ÏÂÎÆâ¤ÇNAD¡Ê¥Ë¥³¥Á¥ó¥¢¥ß¥É¥¢¥Ç¥Ë¥ó¥¸¥Ì¥¯¥ì¥ª¥Á¥É¡Ë¤ËÊѲ½¤·¤Þ¤¹¡£

NAD¤Ï¤µ¤Þ¤¶¤Þ¤ÊÂå¼Õ¤Ë´Ø¤ï¤ë½ÅÍפÊÊä¹ÚÁǤǡ¢¤½¤ÎƯ¤­¤Î°ì¤Ä¤ËÏ·²½¤Ë´Ø¤ï¤ë°äÅÁ»Ò¤Ç¤¢¤ë¥µ¡¼¥Á¥å¥¤¥ó°äÅÁ»Ò¡ÊĹ¼÷°äÅÁ»Ò¡Ë¤Î³èÀ­²½¤¬¤¢¤ê¤Þ¤¹¡£NAD¤Î¹çÀ®·ÐÏ©¤ÏÊ£¿ô¤¢¤ê´Ø·¸¤¹¤ëʪ¼Á¤â¿¤¯Ê£»¨¤Ç¤¹¤¬¡¢¤â¤Î¤¹¤´¤¯Ã±½ã²½¤¹¤ë¤È°Ê²¼¤Ç¤¹¡£

NAD¤Ï¹³Ï·²½¸¦µæ¤Î¥¿¡¼¥²¥Ã¥È¤È¤·¤Æ¸¦µæ¤¬À¹¤ó¤Ç¤¹¡£

²ÃÎð¤äÆÃÄê¤Îɵ¤¤ÇÂÎÆâ¤ÎNAD¤¬¸º¾¯¤¹¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤ª¤ê¡¢²¿¤é¤«¤ÎÊýË¡¤ÇNAD¤òÁý¤ä¤·¤Æ¤ä¤ì¤Ð¹³Ï·²½¤ÎºîÍѤäɵ¤¤ÎͽËÉ¡¦¼£ÎŤ¬¤Ç¤­¤ë¤«¤â¤·¤ì¤Ê¤¤¡¢¤È¤¤¤¦¤Î¤ÏÂÅÅö¤Ê²¾Àâ¤Ç¤¹¡£

¤À¤Ã¤¿¤éNAD¤òľÀÜÀݼ褹¤ì¤Ð¤¤¤¤¤Î¤Ç¤Ï¤Ê¤¤¤«»×¤¤¤Þ¤¹¤¬¡¢NAD¤½¤Î¤â¤Î¤Ïʬ»ÒÎ̤¬Â礭¤¯Àݼ褷¤Æ¤â¤¦¤Þ¤¯ÂÎÆâ¤ÇÍøÍѤµ¤ì¤Þ¤»¤ó¡£NAD¤òÁý¤ä¤¹¤¿¤á¤Î¤µ¤Þ¤¶¤Þ¤Ê¥¢¥×¥í¡¼¥Á¤¬¤¢¤ê¡¢NMN¤Ï¤½¤Î°ì¤Ä¤Ç¤¹¡£

¢£¥Ò¥È¤ËÂФ¹¤ë¼Â¸³¤â½½Ê¬¤Ê¤â¤Î¤Ç¤Ï¤Ê¤¤

ưʪ¼Â¸³¤Ç¤Ï´üÂԤǤ­¤ë·ë²Ì¤¬½Ð¤Æ¤¤¤Þ¤¹¡£¥Þ¥¦¥¹¤ËÂФ·12¥«·î´Ö¡¢ÂνÅ1kg¤¢¤¿¤ê100mg¤Þ¤¿¤Ï300mg¤ÎNMN¤òÅêÍ¿¤¹¤ë¤È¡¢Ä̾ï¤Î»ôÎÁ¤Î¤ß¤òÍ¿¤¨¤é¤ì¤¿Âоȷ²¤ÈÈæ¤Ù¤Æ¡¢²ÃÎð¤Ëȼ¤¦ÂνÅÁý²Ã¤¬ÍÞÀ©¤µ¤ì¡¢¿ÈÂγèÆ°¤¬³èȯ¤Ë¤Ê¤ê¡¢¥¤¥ó¥¹¥ê¥ó´¶¼õÀ­¤¬²þÁ±¤·¤Þ¤·¤¿¡Ê¢¨1¡Ë¡£

¤³¤Î¼Â¸³·ë²Ì¤À¤±¤ò¸«¤ì¤Ð¡¢¤ß¤Ê¤µ¤ó¤ÏNMN¤ò¸ú²Ì¤Î¤¢¤ëʪ¼Á¤À¤È»×¤¦¤«¤â¤·¤ì¤Þ¤»¤ó¡£

¤â¤·¡¢»ä¤¬¥µ¥×¥ê¥á¥ó¥È¤ÎÀ½Â¤ÈÎÇä¶È¼Ô¤Ê¤é¡¢¤¤¤¤·ë²Ì¤¬ÆÀ¤é¤ì¤¿¥Þ¥¦¥¹¤Î¼Â¸³·ë²Ì¤ò¶¯Ä´¤·¤Æ¡¢¤¢¤Ê¤¿¤¬¥Þ¥¦¥¹¤Ç¤Ï¤Ê¤¤¤³¤È¤Ë¤Ï¤Ê¤ë¤Ù¤¯¿¨¤ì¤Ê¤¤¤è¤¦¤Ë¤·¤Þ¤¹¡£

ưʪ¼Â¸³¤Ç¤Ïͭ˾¤Ç¤â¡¢¥Ò¥È¤Ç»î¤·¤Æ¤ß¤¿¤é¤½¤¦¤Ç¤â¤Ê¤«¤Ã¤¿¤È¤¤¤¦»öÎã¤Ï¿ô¿¤¯¤¢¤ê¤Þ¤¹¡£

ÄÚÌîµÈ¹§ÀèÀ¸¤Î¡Ö·ò¹¯¾ðÊó¤òɾ²Á¤¹¤ë¥Õ¥í¡¼¥Á¥ã¡¼¥È¡×¤¬»²¹Í¤Ë¤Ê¤ë¤Ç¤·¤ç¤¦¡Ê¢¨2¡Ë¡£¥¹¥Æ¥Ã¥×1¤Î¡Ö¶ñÂÎŪ¤Ê¸¦µæ¤Ë´ð¤Å¤¤¤Æ¤¤¤ë¤«¡×¤Ï¥¯¥ê¥¢¤Ç¤­¤Þ¤¹¤¬¡¢¥¹¥Æ¥Ã¥×2¤Î¡Ö¸¦µæÂоݤϥҥȤ«¡×¤ÎÅú¤¨¤Ï¡Ö¤¤¤¤¤¨¡×¤Ç¡¢¡Ö¥Ò¥È»î¸³¤ÎÊó¹ð¤òÂԤġפËÁêÅö¤·¤Þ¤¹¡£

½Ð½ê¡á¡Ö²Ê³ØŪº¬µò¤Ë´ð¤Å¤¯¾ðÊó¡×¤È¤Î¸þ¤­¹ç¤¤Êý

¡Ö¥Ò¥È»î¸³¤Ï¹Ô¤ï¤ì¤Æ¤¤¤ë¡×¤È¤¤¤¦È¿ÏÀ¤¬Í½ÁۤǤ­¤Þ¤¹¤¬¡¢¤ª¤½¤é¤¯¤½¤ì¤Ï¡¢NMN¤Îñ²óÅêÍ¿¤Ç¤Î°ÂÁ´À­É¾²Á¤Î¤³¤È¤Ç¤·¤ç¤¦¡£10¿Í¤Î·ò¹¯¤ÊÀ®¿ÍÃËÀ­¤òÂоݤË100mg¡¢250mg¡¢500mg¤ÎNMN¤ò1²ó¤À¤±·Ð¸ýÅêÍ¿¤·Í­³²¤Ê¸ú²Ì¤ò´Ñ»¡¤Ç¤­¤Ê¤«¤Ã¤¿¤È¤¤¤¦¸¦µæ¤Ç¤¹¡Ê¢¨3¡Ë¡£

¶È¼Ô¤Î¥µ¥¤¥È¤Ç¤Ï¡Ö°ÂÁ´¤ËÅêÍ¿¤Ç¤­¤ë¤³¤È¤ò¥Ò¥È¤Ç³Îǧ¡×¤Ê¤É¤È½ñ¤¤¤Æ¤¢¤ê¤Þ¤·¤¿¤¬¡¢½÷À­¤äɵ¤¤Î¿Í¤ËÂФ·¤Æ°ÂÁ´¤«¤É¤¦¤«¤Ï¤ï¤«¤ê¤Þ¤»¤ó¡£

·ò¹¯À®¿Í¤Ç¤âĹ´ü´ÖÀݼ褷¤Æ°ÂÁ´¤«¤É¤¦¤«¤â¤ï¤«¤ê¤Þ¤»¤ó¡£10¿Í¤Ç¤Ï¤ï¤«¤é¤Ê¤«¤Ã¤¿¤±¤ì¤É¤â¡¢100¿Í¤Ë1¿Í¤ËÉûºîÍѤ¬½Ð¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£

¢¨1¡¡Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
¢¨2¡¡½Ð½ê¡á¹ñΩ·ò¹¯¡¦±ÉÍܸ¦µæ½ê¤Î¡Ö²Ê³ØŪº¬µò¤Ë´ð¤Å¤¯¾ðÊó¡×¤È¤Î¸þ¤­¹ç¤¤Êý¡ÊVer.191101¡Ë
¢¨3¡¡Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men

¢£¡Ö¸ú²Ì¡×¤Ç¤Ï¤Ê¤¯¡Ö°ÂÁ´À­¡×¤Ë¤Ä¤¤¤Æ¤Î¼Â¸³¤·¤«¹Ô¤ï¤ì¤Æ¤¤¤Ê¤¤

¤³¤Î¸¶¹Æ¤ò¼¹É®¤·¤Æ¤¤¤¿¤³¤í¡¢¿··¿¥³¥í¥Ê¥ï¥¯¥Á¥ó¤¬³¤³°¤Ç¾µÇ§¤µ¤ì»ÈÍѤµ¤ì¤Ï¤¸¤á¤¿¥Ë¥å¡¼¥¹¤¬Î®¤ì¤Æ¤­¤Þ¤·¤¿¡£

¿··¿¥³¥í¥Ê¥ï¥¯¥Á¥ó¤ÎÎ×¾²»î¸³¤Ç¤Ï¿ôËü¿Í¤ËÀܼ路¤¿¾å¤Ç¿ô½µ´Ö´Ñ»¡¤·¡¢¥ï¥¯¥Á¥ó¤Ë´ØÏ¢¤·¤¿½ÅÆƤÊÍ­³²»ö¾Ý¤¬µ¯¤­¤Æ¤¤¤Ê¤¤¤³¤È¤Ï³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢¤½¤ì¤Ç¤â¼ÂºÝ¤Ë»È¤Ã¤Æ¤ß¤Æ»×¤ï¤ÌÉûºîÍѤ¬¤ª¤­¤ë¤«¤â¤·¤ì¤Ê¤¤¤³¤È¤òǰƬ¤Ë¤ª¤¤¤Æ¿µ½Å¤Ë´Ñ»¡¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

¥µ¥×¥ê¥á¥ó¥È¤Ê¤é10¿Í¤ËÂФ·¤Æñ²óÅêÍ¿¤·¤«¤·¤Æ¤¤¤Ê¤¯¤Æ¤â¡Ö°ÂÁ´¤ËÅêÍ¿¤Ç¤­¤ë¤³¤È¤ò¥Ò¥È¤Ç³Îǧ¡×¤Ê¤ó¤Æ½ñ¤±¤Æ¤·¤Þ¤¤¤Þ¤¹¡£¤³¤Î¤è¤¦¤Ê¤³¤È¤òÁ°Äó¤Ë¤¹¤ë¤È¡¢¤³¤ÎÇä¤êʸ¶ç¤¬¤¤¤«¤ËÍê¤ê¤Ê¤¤¤«¤¬¤ªÊ¬¤«¤ê¤¤¤¿¤À¤±¤ë¤È»×¤¤¤Þ¤¹¡£

¤Ê¤ª¡¢NMN¤Ë¤Ä¤¤¤Æ¤ÏƱ¤¸¸¦µæ¥°¥ë¡¼¥×¤ÇĹ´üÅêÍ¿¤Î·ò¾ï¼Ô¤ËÂФ¹¤ë°ÂÁ´À­³Îǧ»î¸³¡ÊÂè­¶Áê»î¸³¡Ë¤¬¿Ê¹ÔÃæ¤Ç¤¹¡Ê¢¨4¡Ë¡£¤Þ¤À·ë²Ì¤Ï½Ð¤Æ¤¤¤Þ¤»¤ó¡£

¤·¤«¤â¡¢¤¢¤¯¤Þ¤Ç¼çÌÜŪ¤Ï°ÂÁ´À­¤Î³Îǧ¤Ç¤¢¤Ã¤Æ¡¢¸ú²Ì¤ò³Îǧ¤¹¤ë¸¦µæ¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£»ä¤¬Ä´¤Ù¤¿ÈÏ°ÏÆâ¤Ç¤Ï¡¢NMN¤Î¸ú²Ì¤ò¸¡¾Ú¤¹¤ëÎ×¾²»î¸³¤Ïȯɽ¤µ¤ì¤Æ¤¤¤Þ¤»¤ó¤·¡¢¤½¤â¤½¤âͽÄꤹ¤é¤¢¤Þ¤ê¤Ê¤¤¡¢¤È¤¤¤¦¾õÂ֤Ǥ¹¡£¥Ò¥È¤Ë¤ª¤±¤ëĹ´üÅêÍ¿¤Î°ÂÁ´À­¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤»¤ó¤Î¤ÇÅö¤¿¤êÁ°¤Ç¤¹¡£

¢¨4¡¡UMIN000030609¡¢¡ØÀ¸ÂÎÆâʪ¼ÁNicotinamide mononucleotide¤ÎĹ´üÅêÍ¿¤Î·ò¾ï¼Ô¤ËÂФ¹¤ë°ÂÁ´À­³Îǧ»î¸³¡ÊÂè­¶Áê»î¸³¡Ë¡ÊNicotinamide mononucleotide¤Îµ¡Ç½À­É½¼¨¿©Éʳ«È¯¤òÌܻؤ·¤¿¥á¥¿¥Ü¥ê¥Ã¥¯¥·¥ó¥É¥í¡¼¥à´ØÏ¢»Øɸ²þÁ±¤ÎÎ×¾²»î¸³¡Ë¡Ù

¢£¸º¤Ã¤Æ¤¤¤ë¤«¤é¤È¤¤¤Ã¤ÆÁý¤ä¤»¤Ð¤¤¤¤¤ï¤±¤Ç¤Ï¤Ê¤¤

¤½¤â¤½¤â¡¢¡ÖNAD¤Ï²ÃÎð¤Ëȼ¤¤¸º¾¯¤¹¤ë¤¿¤á¡¢NAD¤òÁý¤ä¤»¤Ð¥¢¥ó¥Á¥¨¥¤¥¸¥ó¥°¤Î¸ú²Ì¤¬¤¢¤ë¡×¤È¤¤¤¦¤Î¤Ï²¾Àâ¤Ë¤¹¤®¤Þ¤»¤ó¡£¸º¾¯¤·¤Æ¤¤¤ë¤«¤éÊ䤨¤Ð¤¤¤¤¡¢¤È¤¤¤¦°Âľ¤Ê¹Í¤¨¤Ï»þ¤Ë´í¸±¤Ç¤¹¡£

¼ÂÎã¤ÇÀâÌÀ¤¹¤ë¤Î¤¬¤ï¤«¤ê¤ä¤¹¤¤¤Ç¤·¤ç¤¦¡£Å´¤ÏÀÖ·ìµå¤Ë´Þ¤Þ¤ì¤Æ¤¤¤ë¥Ø¥â¥°¥í¥Ó¥ó¤ÎºàÎÁ¤Ç¤¢¤ê¡¢Å´Ê¬¤¬ÉÔ­¤¹¤ë¤ÈÉÏ·ì¤Ë¤Ê¤ë¤³¤È¤Ï¤è¤¯ÃΤé¤ì¤Æ¤¤¤Þ¤¹¡£

Å´·ç˳À­ÉÏ·ì¤Ç¤Ï¡¢·ì±Õ¸¡ºº¤Ç·ìÀ¶Ãæ¤ÎÅ´¤Î¿ôÃͤ¬Ä㤯¤Ê¤ê¤Þ¤¹¡£¤¿¤À¡¢·ìÀ¶Å´¤¬Äã²¼¤·¤Æ¤¤¤ëÉϷ줬¤ß¤ÊÅ´·ç˳À­ÉÏ·ì¤È¤Ï¸Â¤ê¤Þ¤»¤ó¡£

¡ÖËýÀ­¼À´µ¤Ëȼ¤¦ÉÏ·ì¡×¤Ç¤âƱ¤¸¤è¤¦¤ËºÎ·ì¸¡ºº¤Ç·ìÀ¶Å´¤¬Äã²¼¤·¡¢´ð½àÃͰʲ¼¤Ë¤Ê¤ê¤Þ¤¹¡£¤·¤«¤·¡¢ÉÏ·ì¤Î¸¶°ø¤Ç¤¢¤ëËýÀ­¼À´µ¤ò¤½¤Î¤Þ¤Þ¤Ë¤·¤ÆÅ´¤À¤±Êäµë¤·¤Æ¤âÉÏ·ì¤Ï¤è¤¯¤Ê¤ê¤Þ¤»¤ó¡£¿Í´Ö¤ÎÂΤÏÊ£»¨¤Ç¡¢¸¡ºº¤Ç¿ô»ú¤¬Ä㤤¤«¤é¤È¤¤¤Ã¤ÆÊä½¼¤·¤Æ¤ä¤ì¤Ð¤¤¤¤¤È¤¤¤¦Ã±½ã¤Ê¤â¤Î¤Ç¤Ï¤Ê¤¤¤Î¤Ç¤¹¡£

¤è¤¯¤Ê¤é¤Ê¤¤¤À¤±¤Ê¤é¤Þ¤À¤·¤â¡¢¸º¾¯¤·¤Æ¤¤¤ëÀ®Ê¬¤Î°Â°×¤ÊÊä½¼¤Ï¤«¤¨¤Ã¤Æɵ¤¤ò°­¤¯¤¹¤ë¤³¤È¤â¤¢¤ê¤Þ¤¹¡£ËýÀ­¼À´µ¤Ëȼ¤¦ÉÏ·ì¤Î¸¶°ø¤Ï¡¢´¶À÷¾É¤ä¼«¸ÊÌȱÖÀ­¼À´µ¤Ê¤É¤Î±ê¾É¤Ç¤¹¤¬¡¢Å´ºÞ¤ÎÊä½¼¤Ï¤³¤ì¤é¤Î¼À´µ¤ò¡¢¤È¤¯¤ËºÙ¶Ý¤Ë¤è¤ë´¶À÷¾É¤ò°­²½¤µ¤»¤Þ¤¹¡£

¥Ò¥È¤¬¿Ê²½¤·¤Æ¤­¤¿´Ä¶­¤Ç¤ÏºÙ¶Ý´¶À÷¾É¤Ï¤¢¤ê¤Õ¤ì¤¿Éµ¤¤Ç¡¢ÂΤÏɸ¶ÂΤËÂФ¹¤ëÂй³¼êÃʤòȯ㤵¤»¤Þ¤·¤¿¡£

Å´¤Ï¥Ø¥â¥°¥í¥Ó¥ó¤ÎºàÎÁ¤Ç¤¢¤ë¤ÈƱ»þ¤Ë¡¢ºÙ¶Ý¤¬Áý¿£¤¹¤ë¤¿¤á¤ËɬÍפʻñ¸»¤Ç¤â¤¢¤ê¤Þ¤¹¡£±ê¾É¤¬µ¯¤­¤ë¤ÈÅ´¤ÎµÛ¼ý¤äÍøÍѤ¬ÍÞÀ©¤µ¤ì¤ë¤Î¤Ï´¶À÷¾É¤ËÂФ¹¤ëÂΤÎËɸîÈ¿±þ¤À¤È¸À¤ï¤ì¤Æ¤¤¤Þ¤¹¡Ê¢¨5¡Ë¡£

ÂΤòÅ´ÉÔ­¤Ë¤¹¤ë¤³¤È¤ÇÉÏ·ì¤Ë¤Ï¤Ê¤ê¤Þ¤¹¤¬¡¢ºÙ¶Ý¤ËÂФ·¤Æ¤ÏʼÎȹ¶¤á¤Ë¤Ê¤ê¤Þ¤¹¡£¤¤¤ï¤ÐÆù¤òÀڤ餻¤Æ¹ü¤òÃǤġ¢¤È¤¤¤Ã¤¿¤È¤³¤í¤Ç¤·¤ç¤¦¤«¡£ºÙ¶Ý¤¬ÍøÍѤǤ­¤Ê¤¤¤è¤¦¤»¤Ã¤«¤¯ÂΤ¬·ìÀ¶Å´¤òÄ㤯ÊݤäƤ¤¤ë¤È¤³¤í¤ËÅ´¤òÅêÍ¿¤¹¤ì¤Ð´¶À÷¾É¤¬°­²½¤·¤Æ¤·¤Þ¤¤¤Þ¤¹¡£

¢¨5¡¡Evaluation of iron deficiency as a nutritional adaptation to infectious disease: an evolutionary medicine perspective

¢£¤¬¤ó¤ò°­²½¤µ¤»¤ë²ÄǽÀ­¤â»ØŦ¤µ¤ì¤Æ¤¤¤ë

¤Ò¤ë¤¬¤¨¤Ã¤Æ¡¢²ÃÎð¤Ëȼ¤¦NAD¤Î¸º¾¯¤Ï¤É¤¦¤Ç¤·¤ç¤¦¤«¡£

NAD¤ÎÄã²¼¤¬²ÃÎð¤Î¸¶°ø¤Ç¤¢¤ì¤Ð¡¢NAD¤òÁý¤ä¤¹NMN¥µ¥×¥ê¥á¥ó¥È¤Ï¥¢¥ó¥Á¥¨¥¤¥¸¥ó¥°¤ÎÍ­±×¤ÊºîÍѤ¬¤¢¤ë¤Ç¤·¤ç¤¦¡£

¤·¤«¤·¡¢·ìÀ¶Å´¤Î¸º¾¯¤¬´¶À÷¾É¤ËÂФ¹¤ëŬ±þŪ¤ÊÈ¿±þ¤Ç¤¢¤ë¤Î¤ÈƱÍͤˡ¢NAD¤Î¸º¾¯¤¬²¿¤é¤«¤ÎÍ­³²¤Ê¸½¾Ý¤ËÂФ¹¤ëŬ±þŪ¤ÊÈ¿±þ¤Ç¤¢¤ì¤Ð¡¢NMN¥µ¥×¥ê¥á¥ó¥È¤ÎÀݼè¤Ï¤«¤¨¤Ã¤Æ³²¤ò¤â¤¿¤é¤·¤Þ¤¹¡£

¥µ¥×¥ê¥á¥ó¥È¤òÇä¤ê¤¿¤¤¿Í¤¿¤Á¤Ï¸ÀµÚ¤·¤Þ¤»¤ó¤¬¡¢NAD¤òÁý²Ã¤µ¤»¤ë¤È¤¬¤ó¤ò°­²½¤µ¤»¤ë²ÄǽÀ­¤¬»ØŦ¤µ¤ì¤Æ¤¤¤Þ¤¹¡Ê¢¨6¡Ë¡£

¼Ì¿¿¡áiStock.com¡¿fatido
¢¨¼Ì¿¿¤Ï¥¤¥á¡¼¥¸¤Ç¤¹ - ¼Ì¿¿¡áiStock.com¡¿fatido

¤¬¤óºÙ˦¤Ï¥¨¥Í¥ë¥®¡¼¤ò»ÀÁǤËÍê¤é¤Ê¤¤Âå¼Õ·ÐÏ©¤Ë°Í¸¤·¡¢NAD¤Ï¤½¤ÎÂå¼Õ·ÐÏ©¤Ç¤â½ÅÍפÊÌò³ä¤ò²Ì¤¿¤·¤Æ¤¤¤Þ¤¹¡£¤¬¤óºÙ˦¤Ë¤è¤Ã¤Æ¤ÏNAD¤ò¹çÀ®¤¹¤ë¹ÚÁǤ¬²á¾ê¤Ëȯ¸½¤·¤Æ¤¤¤Æ¡¢ºÙ˦Æâ¤ÎNADÇ»ÅÙ¤¬¹â¤¤¤³¤È¤¬¤ï¤«¤Ã¤Æ¤¤¤Þ¤¹¡£

¤Þ¤¿¡¢NAD¤ò¹çÀ®¤¹¤ë¹ÚÁǤòÁ˳²¤¹¤ë¤È¤¬¤óºÙ˦¤ÎÁý¿£¤¬ÍÞÀ©¤µ¤ì¤Þ¤¹¡£¤¬¤ó¼£ÎÅÌô¤Î¸õÊä¤È¤·¤Æ¡¢¤¬¤óºÙ˦¤ÎNAD¤ò¸Ï³é¤µ¤»¤ëʪ¼Á¤¬¸¦µæ¤µ¤ì¤Æ¤¤¤ë¤°¤é¤¤¤Ç¤¹¡£

¢¨6¡¡NAD Metabolism in Cancer Therapeutics

¢£ÉûºîÍѤâʬ¤«¤é¤ºÉþÍѤ¹¤ë¤Î¤ÏÅÒ¤±¤Ç¤·¤«¤Ê¤¤

¤³¤ì¤Ï»ä¤Î¸Ä¿ÍŪ¤Ê¿ä¬¤Ç¤¹¤¬¡¢²ÃÎð¤Ëȼ¤Ã¤ÆÂÎÆâ¤ÎNAD¤¬¸º¾¯¤¹¤ë¤Î¤Ï¡¢¤¬¤ó¤ËÂй³¤¹¤ëËɸîÈ¿±þ¤«¤â¤·¤ì¤Þ¤»¤ó¡£

NAD¤¬ÂΤˤ褤Ư¤­¤·¤«¤·¤Ê¤¤¤Î¤Ç¤¢¤ì¤Ð¡¢ÂΤÏǯÎð¤Ë´Ø·¸¤Ê¤¯¤É¤ó¤É¤óNAD¤ò¹çÀ®¤¹¤ì¤Ð¤¤¤¤¤Î¤Ç¤¹¡£»ä¤¿¤Á¤ÎÂΤ¬¤½¤¦¤·¤Ê¤¤¤Î¤Ï¡¢²¿¤«Íýͳ¤¬¤¢¤Ã¤Æ¤Î¤³¤È¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£

¤¿¤È¤¨¤Ð¡¢¤¬¤ó¤Î¥ê¥¹¥¯¤¬¾®¤µ¤¤¼ã¤¤¤¦¤Á¤ÏNAD¥ì¥Ù¥ë¤ò¹â¤¯ÊݤÁ¡¢¤¬¤ó¤Î¥ê¥¹¥¯¤¬Â礭¤¯¤Ê¤Ã¤Æ¤­¤¿Ç¯Îð¤Ë㤹¤ë¤È¡¢¤¬¤óºÙ˦¤ËÍøÍѤµ¤ì¤Ê¤¤¤è¤¦¾¯¤·¤º¤ÄNAD¥ì¥Ù¥ë¤òÄ㤯¤¹¤ë¤è¤¦Ä´Àᤷ¤Æ¤¤¤ë¡¢¤È¤«¡£

¤¿¤À¡¢¾¯¤Ê¤¯¤È¤â¥Þ¥¦¥¹¤Ç¤ÏNMN¤¬¤¬¤ó¤ò°ú¤­µ¯¤³¤¹¤Ê¤ó¤Æ¸½¾Ý¤Ï´Ñ»¡¤µ¤ì¤Æ¤¤¤Þ¤»¤ó¤Î¤Ç¡¢»ä¤Î¼è¤ê±Û¤·¶ìÏ«¤«¤â¤·¤ì¤Þ¤»¤ó¡£

¤Ç¤¹¤¬¡¢ÅöÁ³¤Î¤³¤È¤Ê¤¬¤é¥Þ¥¦¥¹¤È¥Ò¥È¤Ï°ã¤¦À¸¤­Êª¤Ç¤¹¡£ËÜÅö¤ËÂç¾æÉפ«¤É¤¦¤«¤Ï¡¢NMN¥µ¥×¥ê¤òÀݼ褷¤¿¿Í¤¿¤Á¤òĹ´ü´Ñ»¡¤·¤Æ¡¢¤É¤Î¤è¤¦¤Ê¤¬¤ó¤¬¤É¤ì¤°¤é¤¤È¯¾É¤¹¤ë¤Î¤«¿ô¤¨¤Æ¤ß¤Ê¤¤¤È¤ï¤«¤ê¤Þ¤»¤ó¡£

¥¢¥ó¥Á¥¨¥¤¥¸¥ó¥°¤Î¸ú²Ì¤¬¤¢¤ë¤Û¤¦¤ËÅÒ¤±¤Æ¡¢NMN¥µ¥×¥ê¤òÀݼ褷¤¿¤¤¿Í¤Ï¼«Í³¤Ë¤½¤¦¤¹¤ì¤Ð¤¤¤¤¤Ç¤¹¤¬¡¢»ä¤Ï¤ä¤á¤Æ¤ª¤­¤Þ¤¹¡£¤â¤Á¤í¤ó¡¢²È²¤äÃΤê¹ç¤¤¤Ë¤âÀݼ褹¤ë¤³¤È¤ò´«¤á¤Þ¤»¤ó¡£

¢£Å¬Àڤʾò·ï¤Î¤â¤È¤ÇÎ×¾²»î¸³¤ò¤¹¤ë¤Ù¤­

¤½¤ì¤Ë¤·¤Æ¤â¡¢¥Ò¥È¤ËÂФ¹¤ë¸ú²Ì¤â³²¤â¤è¤¯¤ï¤«¤é¤Ê¤¤¤Þ¤ÞNMN¥µ¥×¥ê¤¬ÈÎÇ䤵¤ì¡¢¾ÃÈñ¤µ¤ì¤Æ¤¤¤ë¸½¾õ¤Ï¤¿¤¤¤Ø¤ó¤Ë¤â¤Ã¤¿¤¤¤Ê¤¤¤È»×¤¤¤Þ¤¹¡£

NMN¤òÀݼ褷¤Æ¤¤¤ë¿Í¤ÎÃ椫¤é¡¢¤¬¤ó¤Ë¤«¤«¤Ã¤¿¤ê¡¢Ë´¤¯¤Ê¤Ã¤¿¤ê¤¹¤ë¿Í¤âɬ¤º½Ð¤Æ¤­¤Þ¤¹¤¬¡¢¤½¤ì¤ò¿ô¤¨¤ë¥·¥¹¥Æ¥à¤Ï¤Ê¤¯¡¢NMN¤Î¤»¤¤¤Ê¤Î¤«¶öÁ³¤Ê¤Î¤«¤ï¤«¤ê¤Þ¤»¤ó¡£²¿¿Í¤¬¤É¤ì¤°¤é¤¤NMN¤òÀݼ褷¤Æ¤¤¤ë¤«¤Î¥Ç¡¼¥¿¤â¤¢¤ê¤Þ¤»¤ó¡£

¤³¤Î¤Þ¤Þ¤Ç¤ÏNMN¤Î¸ú²Ì¤ä³²¤¬¤É¤ì¤°¤é¤¤¤¢¤ë¤Î¤«¤ï¤«¤é¤Ê¤¤¤Þ¤Þ¤Ç¤¹¡£

¼Ì¿¿¡áiStock.com¡¿metamorworks
¢¨¼Ì¿¿¤Ï¥¤¥á¡¼¥¸¤Ç¤¹ - ¼Ì¿¿¡áiStock.com¡¿metamorworks

¥Ó¥¸¥Í¥¹¤Î´ÑÅÀ¤«¤é¸À¤¨¤Ð¡¢Î×¾²»î¸³¤ÇÍ­¸úÀ­¤ä°ÂÁ´À­¤¬³Îǧ¤µ¤ì¤Ê¤¯¤Æ¤â¡¢¡Ö¤¤¤¤´¶¤¸¤ÎÀëÅÁʸ¶ç¡×¤Ç¿¤¯¤Î¿Í¤¿¤Á¤òÄà¤Ã¤Æ¤¿¤¯¤µ¤ó¥µ¥×¥ê¥á¥ó¥È¤òÇä¤ë¤Î¤¬ºÇŬ²ò¤Ç¤·¤ç¤¦¡£

¤Ç¤¹¤¬¡¢°å³Ø¤Î´ÑÅÀ¤«¤é¤Ï¤­¤Á¤ó¤ÈÎ×¾²»î¸³¤Ç¸ú²Ì¤ò¸¡¾Ú¤¹¤ë¤Î¤¬Ë¾¤Þ¤·¤¤¤Ç¤¹¡£¤è¤¤·ë²Ì¤¬ÆÀ¤é¤ì¤ì¤Ð¤è¤ê¿¤¯¤Î¿Í¤Ë»È¤Ã¤Æ¤â¤é¤¨¤Þ¤¹¤·¡¢¸ú²Ì¤¬¤Ê¤¤¤È¤ï¤«¤ì¤Ð¤½¤ì°Ê¾å̵Â̶â¤ò»È¤ï¤Ê¤¯¤Æ¤âºÑ¤ß¤Þ¤¹¡£

NMN¤ò¸¦µæ¤·¤Æ¤¤¤ëÀìÌç²È¤¿¤Á¤â¡¢¸ú²Ì¤Ë´üÂԤϤ·¤Ä¤Ä¤â¥Ò¥È¤Ø¤Î±þÍѤϺ£¸å¤Î¸¦µæ¤¬É¬ÍפȤ¤¤¦Ç§¼±¤ò¼¨¤·¤Æ¤¤¤Þ¤¹¡£

¢£¶È¼Ô¤ÎÇä¤êʸ¶ç¤Ë¤À¤Þ¤µ¤ì¤Æ¤Ï¤¤¤±¤Ê¤¤

NMN¥µ¥×¥ê¥á¥ó¥È¤ò´«¤á¤Æ¤¤¤ë¤Î¤ÏÈóÀìÌç²È¤Ç¡¢Â¿¤¯¤Ï¥µ¥×¥ê¥á¥ó¥È¤ÎÈÎÇ䤫¤éÍø±×¤òÆÀ¤é¤ì¤ë¿Í¤¿¤Á¤Ç¤¹¡£¶âÁ¬Åª¤ÊÍø±×¤¬¤«¤é¤à¤È¾ðÊóÄ󶡤â¤æ¤¬¤ß¤Þ¤¹¡£¤è¤¤·ë²Ì¤¬ÆÀ¤é¤ì¤¿Æ°Êª¼Â¸³¤ä¤´¤¯¾¯¿Í¿ô¤Î°ÂÁ´À­»î¸³¤ò¶¯Ä´¤·¡¢ÀøºßŪ¤Ê¥ê¥¹¥¯¤Ë¤Ï¿¨¤ì¤Þ¤»¤ó¡£

¶È¼Ô¤Ë¤â¤è¤ê¤Þ¤¹¤¬¡¢¤Ó¤Ã¤¯¤ê¤¹¤ë¤°¤é¤¤¹â²Á¤ÊNMN¥µ¥×¥ê¥á¥ó¥È¤âÇä¤é¤ì¤Æ¤¤¤Þ¤¹¡£¤Ê¤«¤Ë¤Ï¡¢60γ¤Ç12Ëü±ß¤È¤¤¤¦¾¦Éʤ⤢¤ê¤Þ¤¹¡£Í­¾Ý̵¾Ý¤Î¥µ¥×¥ê¥á¥ó¥È¶È¼Ô¤Ë¤Ç¤Ï¤Ê¤¯¡¢¿¿ÌÌÌܤ˸¦µæ¤·¤Æ¤¤¤ë¸¦µæ¼Ô¤Ë¤ª¶â¤¬Î®¤ì¤Æ¡¢¤·¤Ã¤«¤ê¤·¤¿¸¦µæ¤¬¤Ê¤µ¤ì¤ë¤è¤¦¤Ë¤Ê¤ë¤³¤È¤ò´ê¤¤¤Þ¤¹¡£

NMN¤Ë¤Ä¤¤¤Æʬ¤«¤Ã¤Æ¤ë¤³¤È¤Ï¤ª¤ª¤è¤½°Ê¾å¤Ë¤Ê¤ê¤Þ¤¹¡£¸ú²Ì¤â³²¤âÉÔÌÀ³Î¤Ê¤ï¤ê¤Ë¹â²Á¤Ê¤¿¤á¡¢¸½¾õ¤Ç¤ÏNMN¥µ¥×¥ê¥á¥ó¥È¤ò¤ª¤¹¤¹¤á¤·¤Þ¤»¤ó¡£¤ª¶â¤µ¤¨½Ð¤»¤Ð³Ú¤Ë·ò¹¯¤Ë¤Ê¤ì¤ë¤È¤¤¤¦¡¢¤¦¤Þ¤¤ÏäϤ½¤¦¤½¤¦¤¢¤ë¤â¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤¹¡£¶È¼Ô¤ÎÇä¤êʸ¶ç¤Ë¤À¤Þ¤µ¤ì¤Ê¤¤¤è¤¦¤Ë¤·¤Þ¤·¤ç¤¦¡£

----------
̾¼è ¹¨¡Ê¤Ê¤È¤ê¡¦¤Ò¤í¤à¡Ë
Æâ²Ê°å
°å³ØÉô¤ò´¶È¸å¡¢Âç³Øɱ¡¶Ð̳¡¢Âç³Ø±¡¤Ê¤É¤ò·Ð¤Æ¡¢¸½ºß¤ÏÊ¡²¬¸©¤Î»ÔÃæɱ¡¤Ë¶Ð̳¡£¿ÇÎŤΤ«¤¿¤ï¤é¡¢¥¤¥ó¥¿¡¼¥Í¥Ã¥È¾å¤Ç°åÎÅ¡¦·ò¹¯¾ðÊó¤Î¸«¶Ë¤áÊý¤òȯ¿®¤·¤Æ¤¤¤ë¡£Ãø½ñ¤Ë¡Ø¿·ÁõÈǡ֥˥»°å³Ø¡×¤ËñÙ¤µ¤ì¤Ê¤¤¤¿¤á¤Ë¡Ù¡ÊÆâ³°½ÐÈǼҡˡ£
----------

¡ÊÆâ²Ê°å ̾¼è ¹¨¡Ë